Despite of the fact that GATA4 is widely epigenetically silenced in lung cancer, the impacts of GATA4 silencing on tumorigenesis and corresponding cancer therapeutic strategies remain largely unexplored. This evidence concerns the gene GATA4 and lung carcinoma.